Share this to:

Support & Insight for the Autumn of Life

Begone 2020: Despite COVID, Alzheimer’s Research Advanced

ALZFORUM: Last year, people with dementia were most vulnerable, and this constrained research. Investigators adjusted and managed to make strides in important areas, from plasma tests for Aβ and tau to therapeutics. 2020 saw the first — if embattled — FDA filing for a new AD drug since 2003. If approved, it would be the first biologic treatment for this disease.


Last year was a year to remember. (Or make that a year to forget!) Hope held until February that SARS-CoV-2 might be contained, but was quickly dashed when the virus spread across the globe. Lockdowns, social isolation, protective equipment shortages, and heartbreak became the norm as millions of people became infected and the death toll soared, especially among the old.

People with dementia were most vulnerable, and this constrained research. Clinical studies and trials were hampered because in-person visits had to be cancelled or rescheduled. Basic research was disrupted. Laboratories worldwide were forced to shutter or curtail access, putting projects on ice and precious cell and animal lines in jeopardy. Conference organizers scrambled to reschedule or switch to an online format, with various degrees of success. Casualties included the Society for Neuroscience annual meeting. Typically drawing up to 30,000 scientists annually, it was cancelled.

By June, investigators had adjusted and research began to get mostly back on track.

Some clinical trials were abandoned (Jun news), but even so, as outlined in this yearly research roundup, the field overall managed to make strides in important areas, from plasma tests for Aβ and tau to therapeutics. Twenty-twenty saw the first—if embattled—FDA filing for a new AD drug since 2003. If approved, it would be the first biologic treatment for this disease.

Read the complete article at AlzForum.org.

Subscribe
Notify of
guest

0 Comments
Inline Feedbacks
View all comments
B. Berger

B. Berger

Visit Our Pages On:

Welcome

This site was inspired by my Mom’s autoimmune dementia.

It is a place where we separate out the wheat from the chaffe, the important articles & videos from each week’s river of news. With a new post on Alzheimer’s or dementia appearing on the internet every 7 minutes, the site’s focus on the best information has been a help to many over the past 15 years. Thanks to our many subscribers for your supportive feedback.

The site is dedicated to all those preserving the dignity of the community of people living with dementia.

Peter Berger, Editor

Related

a413-Stemcells-W160.jpeg
Princeton Fast-Tracks New Path for Treating Alzheimer's
Princeton University set its sights on preventing amyloid-beta plaque, the most notorious culprit behind Alzheimer's....
1071.jpeg
ClockMe Computerized Dementia Self-Test Created at Georgia Tech
See Georgia Tech's simple-to-use computer program that allows adults to screen themselves for early signs of dementia.
140302-silver.jpeg
Nanosilver Warning
Alzheimer's is characterized by an overproduction of free radicals in cells. That's why incredibly tiny "nanoparticl...

Books

Amazon Books
0
Would love your thoughts, please comment.x
()
x
News to Get at the Truth

Subscribe To Our Weekly Newsletter

Enjoy thought-provoking videos & articles
News to Get at the Truth

Subscribe To Our Weekly Newsletter